Concord Biotech share price extends gain after listing at 21% premium
Live MintDespite weak market sentiments, Concord Biotech share price opened at ₹900 apiece on both NSE and BSE, delivering over 21 per cent listing premium to the lucky allottees. On NSE, Concord Biotech share price opened at ₹900.05 apiece and went on to hit intraday high of ₹925.90 per share. The company's strong fundamentals and good subscription levels were positive factors for this.” Concord Biotech share price target On suggestion to allottees after positive debut, Vaibhav Kaushik, Research Analyst at GCL Broking said, “Concord Biotech IPO was a candidate for four digit listing but due to weak stock market sentiments, it has listed at ₹900 apiece levels. However, in case it doesn't come below ₹900 and becomes available around ₹880, then one should look at other IPO and shares available in the market.” “In case Concord Biotech shares become available at ₹880, one should buy with stop loss at ₹860 levels for ₹1,000 apiece target,” concluded Vaibhav Kaushik.
History of this topic
Concord Enviro Systems IPO Day 3: Should you apply or not? Check GMP, subscription status, review and more
Live Mint
Concord Enviro Systems IPO Opens Tomorrow, Check Price Band And Other Details Here
ABP News
Concord Biotech shares list with 21% premium at ₹900 apiece on BSE
Live Mint
Concord Biotech IPO allotment date likely today. GMP, how to check status online
Live Mint
Concord Biotech IPO subscribed 2.72 times on day 2; retail portion booked 2.26x
Live MintDiscover Related
